However, Dhh expression was downregulated in old mice both healthy and ischemic conditions, impairing muscle recovery, these conditions can be ameliorated through Dhh gene therapy, suggesting that Dhh has value as a therapeutic approach for ischemic diseases in the elder population (Renault, Robbesyn, et al., [83]). The gene discussed is DHH; the disease is ischemic disease.